Holistic solutions for HAI and antibiotic resistance
|Coordinator||NHG Sweden AB|
|Funding from Vinnova||SEK 500 000|
|Project duration||May 2013 - January 2014|
|Venture||Challenge-Driven Innovation – Stage 1 initiation|
Purpose and goal
The project aims at establishing joint development projects between research-based pharmaceutical companies, other suppliers and public sector for the development of complete solutions in HAI and resistance addressing a global market The project has developed a methodology and a framework that propose how this is done. The work will go on to form a commercially viable constellation for future initiatives within the scope of this project.
Results and expected effects
The parties have worked out a business model that can be applied in many different contexts in the constellation of public sector and pharmaceutical companies. The model focuses on increased service content and packaging of services and products. The project suggests a framework for development projects involving pharmaceutical companies and public sector and has laid the foundation for similar future projects. Within the specific area Healthcare Associated Infections (HAI), some of the results from the project will be part of the ongoing work to improve care for many patients
Approach and implementation
In the project, the parties have worked continuously with workshops and analysis in parallel. This has been the foundation for the development of project plans and contracts suggested in Phase 2.